Retaglutide jẹ dipeptidyl peptidase-4 (DPP-4) tuntun inhibitor kilasi hypoglycemic oogun ti o le ṣe idiwọ ibajẹ ti glucagon-like peptide-1 (GLP-1) ati glucagon-igbẹkẹle insulin-itusilẹ polypeptide (GIP) nipasẹ DPP-4 henensiamu ninu ifun ati ẹjẹ, ti o fa awọn sẹẹli pancreatic ni ipa lori ifun ati ẹjẹ, nipa ṣiṣe gigun iṣẹ ṣiṣe insulini wọn. ipele basali ti hisulini ãwẹ, lakoko ti o dinku yomijade ti glucagon nipasẹ awọn sẹẹli α pancreatic, nitorinaa ni imunadoko diẹ sii ni iṣakoso suga ẹjẹ lẹhin ti prandial. O ṣe daradara ni awọn ofin ti ipa hypoglycemic, ifarada, ati ibamu.